NanoTess

Pharmaceuticals

NanoTess is a private pharmaceuticals company.

Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
Accelerator/Incubator
Jan 2023
Valuation — not yet established

No valuation for NanoTess is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NanoTess with a free account
  • ·Watch NanoTess: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

NanoTess funding history

1 rounds
DateRoundRaisedPost-money
Jan 2023Accelerator/Incubator—▮
Unlock post-money valuations

Membership and data by Private Market View

How NanoTess's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For NanoTess, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about NanoTess

When did NanoTess last raise?
NanoTess last raised in Jan 2023 (Accelerator/Incubator).